HCPCS code J9267: Paclitaxel injection, per 1 mg2026 Medicare rate & RVUs in Florida
Intravenous paclitaxel, reported by oncology practices for the milligram amount administered as chemotherapy for selected solid tumors and other cancers.
CMS doesn’t publish an office rate for J9267 in Florida.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9267 covers
Paclitaxel is an antineoplastic drug usually given by intravenous infusion. Oncology practices report it when administering chemotherapy for cancers such as breast, ovarian, and non-small-cell lung cancer. This code identifies conventional paclitaxel; the albumin-bound formulation is separately identified by J9264. The drug is typically supplied and administered as part of an oncology treatment visit, alongside a separately reported chemotherapy administration service when appropriate.
CMS assigns this code physician fee schedule status E, excluding it from the physician fee schedule. When Medicare covers the drug, payment is generally handled through the Part B drug method using CMS’s quarterly Average Sales Price pricing files; special Medicare coverage instructions apply. Report the amount administered in milligrams: one HCPCS unit represents 1 mg. The drug code identifies the medication and quantity, not the infusion service.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9267 pays more and less in Florida
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
| Payment locality | Office | Facility |
|---|---|---|
| Fort Lauderdale, FL | Unavailable | Unavailable |
| Miami, FL | Unavailable | Unavailable |
| Rest of Florida | Unavailable | Unavailable |
How the J9267 rate is calculated
Each of J9267’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9267
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9267
J9267 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9267
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9267 isn’t priced in this setting.
J9267 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J9264Paclitaxel albumin-boundPer 1 mg
- J9264 identifies the albumin-bound formulation of paclitaxel. J9267 is for conventional paclitaxel.
- 96413Chemo IV infusionInitial drug, first hour
- J9267 reports the paclitaxel drug quantity in milligrams; 96413 reports a qualifying initial chemotherapy infusion service.
- J9263OxaliplatinPer 0.5 mg
- J9263 identifies oxaliplatin, a different chemotherapy drug. Use J9267 for conventional paclitaxel.
J9267 billing questions
When should J9267 be used instead of J9264?
Use J9267 for conventional paclitaxel. J9264 identifies albumin-bound paclitaxel, a different formulation.
How many units should be reported?
Each unit represents 1 mg. Report units based on the milligrams administered.
Does J9267 include the chemotherapy infusion service?
No. J9267 identifies the drug and its quantity; a chemotherapy administration service, such as 96413 when applicable, is reported separately.
How does Medicare treat payment for J9267?
CMS excludes it from the physician fee schedule under status E. When covered, it is generally paid as a Part B drug using CMS quarterly ASP pricing files, with special Medicare coverage instructions.
Does J9267 identify the administration method?
No. It identifies paclitaxel and the milligram quantity; a separate code represents chemotherapy administration when reportable.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9267 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist